Drug intelligence / Profile preview

compound Phellinus igniarius decoction

Development stage
Phase 1
Lead developer
Zhejiang Province Cancer Hospital
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Compound Phellinus igniarius decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by Zhejiang Cancer Hospital for the prevention and treatment of radiation pneumonitis. The preparation is a decoction based on *Phellinus igniarius*, a medicinal fungus traditionally used in East Asia for its anti-tumor and immunomodulatory properties. It is currently being evaluated in clinical trials for its radioprotective effects in patients with thoracic malignant tumors (such as lung or esophageal cancer) receiving radiotherapy. The mechanism of action is thought to involve the reduction of oxidative stress and the modulation of inflammatory cytokines to mitigate radiation-induced lung injury.

Other names
Fufang Sanghuang TangCompound Sanghuang decoction

Beyond the preview

Go deeper on compound Phellinus igniarius decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on compound Phellinus igniarius decoction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call